Medtronic plc (MDT) Financials
Key financial figures for Medtronic plc (Q1 2027).
Medtronic posted Q1 FY2027 revenue of $9.76 billion, up 13.7% both as reported and organically, and raised full-year organic growth and non-GAAP EPS guidance. Revenue reached $9.756 billion, up 13.7% as reported and 13.7% organic, aided by an extra fiscal week that added roughly $570 million to the growth comparison. GAAP diluted EPS was $1.14 (up 40.7% year over year) and non-GAAP diluted EPS was $1.45 (up 15.1%), which management said came in ahead of its own guidance. All four segments grew double digits on a reported basis: Cardiovascular $3.927B (+19.5%), Neuroscience $2.678B (+10.3%), Medical Surgical $2.279B (+10.0%), and Diabetes $843M (+16.9%). On the outlook: Raised FY2027 guidance to organic revenue growth of 7.25%-7.75% (from 6.75%-7.25%) and non-GAAP diluted EPS of $5.94-$6.00 (from $5.90-$6.00). Figures are for Q1 FY2027, as Medtronic plc reported them.
- Revenue
- $9.8B
- Net Income
- $1.5B
- EPS
- $1.15
- Total Assets
- $93.3B
- Operating Cash Flow
- $1.8B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q1 FY2027 | $9.8B | $1.5B | $1.14 | 18.08% | $1.3B |
| Q4 FY2026 | $9.8B | $1.2B | $0.96 | 15.95% | $2.1B |
| Q3 FY2026 | $9.0B | $1.1B | $0.89 | 19.66% | $2.3B |
| Q2 FY2026 | $9.0B | $1.4B | $1.07 | 18.8% | $457M |
| Q1 FY2026 | $8.6B | $1.0B | $0.81 | 16.85% | $584M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $36.4B | $4.8B | $3.73 | 17.78% | $5.4B |
| FY2025 | $33.5B | $4.7B | $3.61 | 17.76% | $5.2B |
| FY2024 | $32.4B | $3.7B | $2.76 | 15.89% | $5.2B |
Frequently asked questions
What was Medtronic plc's revenue last quarter?
Medtronic plc reported revenue of $9.76 billion for Q1 FY2027, up 13.7% from the same period a year earlier.
Is Medtronic plc profitable?
Yes. Medtronic plc reported net income of $1.47 billion for Q1 FY2027, a net margin of 15.07% on revenue.
How has Medtronic plc's margin trended?
Operating margin was 18.08% in Q1 FY2027, compared with 16.85% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
When does Medtronic plc report next?
Medtronic plc is scheduled to report Q2 2027 results on 2026-11-24. The company has confirmed that date.
Full income statement, balance sheet and cash flow for Medtronic plc on SentiSense, with up to forty quarters and twenty fiscal years of history.